Cited by 600Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiac Fibrosis and Remodeling

Acute heart failure syndromes

Open access
Gheorghiade, Mihai, Pang, Peter S.·2009·Journal of the American College of Cardiology

Abstract

Heart failure resulting in hospitalization represents a significant and growing health care burden. Heterogeneity characterizes this group in terms of mode of presentation, pathophysiology, and prognosis. The vast majority of patients symptomatically improve during hospitalization; however, their early post-discharge rehospitalization and mortality rates continue to be high. Worsening signs and symptoms, neurohormonal, and renal abnormalities occurring soon after discharge may contribute to these high post-discharge event rates. Currently available assessment modalities combined with recent advances in cardiovascular therapies provide present-day opportunities to improve post-discharge outcomes. Further investigation into pathophysiologic targets and novel approaches to clinical trial design are needed. Improving post-discharge outcomes is the single most important goal in the management of acute heart failure syndromes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2008.10.041

Cites

180 of 180 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A significant number of patients hospitalized for HFrEF have worsening hemodynamics and/or worsening renal function, which might lead to reluctance with initiating or continuing hemodynamically active therapies.

    “Nevertheless, a significant number of patients hospitalized for HFrEF have worsening hemodynamics and/or worsening renal function, which might lead to reluctance with initiating or continuing hemodynamically active therapies.14-16”

    From CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction (2021) · cites this paper as [14]

    The Prognostic Factors section reports worsening renal function during hospitalization in approximately 30% of patients with acute heart failure syndromes (AHFS). The Clinical Trials section describes worsening hemodynamics in the weeks after discharge, not during hospitalization. The paper does not establish these findings specifically for HFrEF or say that they cause reluctance to initiate or continue hemodynamically active therapies. Page numbers were not available for these passages. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 4

  1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Associa- tion Statistics Committee and Stroke Statistics Subcommittee. Cir- culation 2008;117:e25-146.
  2. Schrier RW. Blood urea nitrogen and serum creatinine: not married in heart failure. Circulation: Heart Fail 2008;1:2-5.
  3. Klein L, Massie BM, Leimberger JD, et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinione for Exacerbation of Chronic Heart Failure (OPTIME-CHF). Circulation: Heart Fail 2008;1:25-33.
  4. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006;355:2099 -112.

Cited by

Sorted by citations

Authors
Gheorghiade, M., & Pang, P. S.
Affiliations
Northwestern University (US)
Corresponding author
Gheorghiade, Mihai
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2009-02
Volume
53
Issue
7
Pages
557-573
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2050481558
Cited by
600
References
180
Citations by year
2026: 11 · 2025: 14 · 2024: 22 · 2023: 23 · 2022: 22 · 2021: 30 · 2020: 20 · 2019: 24 · 2018: 26 · 2017: 47 · 2016: 35 · 2015: 48 · 2014: 45 · 2013: 53 · 2012: 42
FWCI
8.78
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
acute heart failure, hospitalization, post-discharge outcomes, hospital readmission, mortality, renal dysfunction, prognosis, clinical trial design, pathophysiology
MeSH terms
Acute Disease, Heart Failure, Humans, Patient Readmission, Treatment Outcome, Health Care Costs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review